First clinical experience with a new monofocal intraocular lens with enhanced depth of focus

Session Details

Session Title: Extended-Depth-Of-Focus IOLs I

Session Date/Time: Sunday 15/09/2019 | 14:00-16:00

Paper Time: 15:48

Venue: Free Paper Forum: Podium 1

First Author: : I.Baur GERMANY

Co Author(s): :    H. Son   T. Yildirim   P. Poompokawat   R. Khoramnia   G. Auffarth                 

Abstract Details

Purpose:

To evaluate a new monofocal extended depth of focus IOL that meets ISO standards for a monofocal IOL, the exact Mono-EDOF ME4 from Santen.

Setting:

International Vision Correction Research Centre (IVCRC), Department of Ophthalmology, University of Heidelberg, Germany

Methods:

So far 20 patients have been recruited, mean age of patients is 72 ± 7.5 years. All patients underwent cataract surgery with implantation of the Mono EDOF ME4 intraocular lens in both eyes. Postop follow-up examination includes visual acuity testing, defocus curve, contrast sensitivity, halo&glare evaluation.

Results:

So far 29 intraocular Mono-EDOF lenses have been implanted ranging from +19.5 to +27.0 diopters. Follow-up at 3 months postoperatively revealed an uncorrected distance visual acuity of 0.13 logMAR, best corrected distance visual acuity of 0.00 logMAR and binocular uncorrected intermediate visual acuity of 0.16 logMAR. Contrast sensitivity testing showed comparable results as in a healthy population. Photopsia evaluation showed only minimal Halo, Glare and blurred vision.

Conclusions:

The Xact monoEDOF IOL shows good functional results for far and intermediate visual acuity. The defocus curve shows the extended depth of focus. Contrast sensitivity is comparable to the healthy population. Only a low level of photic phenomena was reported by the patients who were very satisfied with the results.

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a competing company, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a competing company, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives non monetary benefits from a competing company, receives non monetary benefits from a company producing, developing or supplying the product or procedure presented, receives consulting fees, retainer, or contract payments from a competing company